Nucleus Pulposus Regeneration Using Injectable Scaffolded Spheroids

Back pain is easy to describe in symptoms and much harder to pin down at the tissue level. In a degenerated intervertebral disc, the nucleus pulposus is not quite doing the same job anymore. It loses some of the hydrated, proteoglycan-rich character that normally helps it bear compression, and once that starts to change, nucleus pulposus regeneration becomes a fairly difficult engineering problem. Cells need to be delivered into a confined space, survive injection, and then function in an environment that is mechanically demanding and biologically restrictive.

That is what makes a recent study out of the Vienna University of Technology interesting. Rather than delivering dispersed cells alone, the researchers built an injectable microtissue system for nucleus pulposus regeneration using spheroids supported by 3D printed microscaffolds. They then tested whether those scaffolded spheroids could better maintain shape, viability, and mechanical behaviour during compression and injection.

The CellScale MicroTester appears early in that story and stays central to it. It was used to measure how the scaffold changed compressive behaviour at the microscale, which turns out to matter quite a bit here. The paper is not only about phenotype. It is also about whether an injectable construct for nucleus pulposus regeneration behaves like something that could plausibly tolerate handling, loading, and delivery.

Why nucleus pulposus regeneration is difficult in degenerated discs

One of the practical problems in nucleus pulposus regeneration is that injectable therapies face two kinds of stress at once. The first is the delivery step itself. Getting cells into the disc is only part of the problem. The injection step itself can be rough on them. Forcing cells through a narrow needle introduces shear and deformation before they ever reach the target site, and that can affect viability right away. Then there is the environment waiting for them once they arrive. The nucleus pulposus is not especially forgiving. It is low in oxygen, limited in nutrients, and quite different from the standard culture conditions used to grow cells beforehand.

That tension shows up in a lot of nucleus pulposus regeneration strategies. Spheroids are appealing because they keep cells in close contact and tend to behave more like a small tissue unit than a suspension of single cells. At the same time, they are soft structures. They can flatten, distort, or come apart more easily during handling and injection. So the issue is not simply whether cells can be delivered into the disc. It is whether they can be delivered in a form that still holds together, both mechanically and biologically, once they get there.

The authors approached that problem by combining spheroids with a printed supporting structure. Their idea was fairly direct: if a spheroid could be mechanically reinforced without losing its ability to differentiate toward a nucleus pulposus-like phenotype, it might serve as a better building block for nucleus pulposus regeneration.

For readers interested in related disc research, we also covered how mechanical stimulation has been studied in intervertebral disc cells in an earlier post on mechanical stimulation of intervertebral disc cells.

How injectable scaffolded spheroids were built for nucleus pulposus regeneration

The study starts with a fairly simple question: what kind of spheroid is the better place to begin? The researchers formed human bone marrow stromal cell spheroids using two starting sizes: 2,000 cells and 3,000 cells. They then compared how those constructs developed. The smaller spheroids ended up being the more convincing option, so the rest of the work moved forward with those.

They then added the part that makes the paper feel different. Around each spheroid, the team fabricated a 200µm polycaprolactone microscaffold using two-photon polymerization. That created what they call a ‘scaffolded spheroid‘. It is a small design change on paper, but it shifts the whole study. At that point, this is no longer just about how spheroids differentiate in culture. It becomes a question of whether a spheroid can be given some structural support without losing what makes spheroids useful in the first place. The scaffold is not just there for culture support. It is meant to function as a reinforcing microstructure during compression and injection.

For nucleus pulposus regeneration, that hybrid design makes sense. A spheroid alone may carry some of the biological benefits of 3D cell aggregation, but it can still be mechanically delicate. A microscaffold alone has structure, but not the dense cellular architecture the researchers were after. The scaffolded spheroid sits somewhere in between. It appears to preserve the compact cellular character of the spheroid while introducing a defined structural shell that can affect how the construct responds to force.

The team then compared differentiation media to see which condition best supported an NP-like phenotype. GDF5 stood out in this system. Relative to the other conditions tested, it produced a more favorable expression pattern for the markers the authors were watching, which is why it became the main differentiation condition used later in the study.

How nucleus pulposus regeneration was supported by NP-like differentiation conditions

The paper also shifts the scaffolded spheroids into culture conditions that look a bit more like the environment they are meant for. Rather than keeping everything in standard high-glucose, normoxic media, the authors moved to low glucose and hypoxia to better reflect the nucleus pulposus niche.

That shift appears to matter. Under low-glucose hypoxic conditions, the scaffolded spheroids showed increased expression of markers associated with an NP-like state, along with higher GAG content and histological evidence of matrix deposition. Aggrecan staining was evident, collagen staining was present, and the overall picture moved closer to what you would want from a construct intended for nucleus pulposus regeneration.

One thing that stands out here is that the paper links biology and mechanics rather than treating them as separate endpoints. The low-glucose hypoxic condition did not just alter marker expression. It also changed the measured mechanical response of the scaffolded spheroids. That becomes clearer in the compression testing results.

How the MicroTester was used to measure nucleus pulposus regeneration constructs

Our MicroTester was used to evaluate the microscale compressive behaviour of the microscaffold, the spheroid, and the scaffolded spheroid. In this study, that part of the workflow is not a side note. It is how the authors tested whether their design for nucleus pulposus regeneration actually changed the physical behaviour of the construct.

Samples were placed in a PBS bath and compressed between plates to 50% of their diameter over five cycles. The researchers then compared force-displacement behaviour, maximum force, and apparent modulus. This gave them a way to ask a more practical question: does the scaffolded spheroid simply look more structured, or does it actually respond differently under repeated loading?

The answer, at least in this system, was yes. The empty microscaffold retained its behaviour across cycles with relatively little force loss. The spheroid alone behaved differently. It showed a larger drop in maximum force across repeated compression and appeared more visibly disrupted after cycling. The scaffolded spheroid held up better. It retained more force over repeated cycles and supported substantially higher loads than the spheroid alone.

That matters for nucleus pulposus regeneration because any injectable construct intended for the disc will face deformation during handling, injection, and loading after placement. A mechanically reinforced construct is not automatically regenerative, of course, but it may be more credible as a delivery format. This is one of the places where the MicroTester data gives the paper its shape. Without those measurements, the scaffold would still look conceptually useful. With the measurements, the authors can show how much the construct changed under compression.

We have also looked at related work on cell spheroid testing, where microscale mechanical measurements were used to study how small 3D cell constructs respond to load.

How nucleus pulposus regeneration constructs changed under disc-like culture conditions

The next part of the paper is where the mechanical results become more interesting. After culture in low-glucose hypoxic conditions, the scaffolded spheroids did not only show NP-like marker changes. Their mechanical response also increased. Maximum force rose substantially, and the apparent elastic modulus moved into a range the authors describe as compatible with native human intervertebral disc values.

That is not the same as saying the construct became native tissue. The system is still a simplified in vitro model. Still, for nucleus pulposus regeneration, this is a meaningful observation. It suggests that the biological conditioning environment may influence not only phenotype but also the mechanical character of the developing construct.

In a lot of tissue engineering studies, mechanics appears late as a confirmatory metric. Here it feels more integrated than that. The scaffold is there from the start, the compression testing is built into the workflow, and the disc-like culture condition appears to influence the same construct from both a biological and physical standpoint.

How injectable scaffolded spheroids supported nucleus pulposus regeneration after 26G injection

Injection was the final practical test in the paper. The authors passed spheroids and scaffolded spheroids through a 26G needle and then looked at morphology, viability, and stress-related gene expression. This section is important because it brings the nucleus pulposus regeneration concept back to the point of delivery.

After a single injection, both groups remained fairly viable. After repeated injections, the difference became more obvious. Spheroids showed more reduction in size and a less favorable response overall, while scaffolded spheroids maintained their structure more effectively and showed lower expression of inflammatory and stress-associated genes such as IL6 and MMP13.

This is one of the more persuasive parts of the paper, mostly because it moves beyond the idea that the scaffold simply stiffens the construct. For nucleus pulposus regeneration, delivery resilience matters just as much. A construct that performs well in culture but is damaged during injection is harder to justify. The scaffolded spheroid appears to hold together better during repeated passage through the needle, which is exactly the kind of issue researchers worry about when thinking about intradiscal delivery.

The study also included an in vitro injection model where NP-like scaffolded spheroids were introduced into an agarose cavity. After injection, the constructs fused into a larger tissue-like mass with minimal dead cells visible. That result does not prove disc repair, but it does make the delivery concept easier to picture.

Why these results matter for nucleus pulposus regeneration

What the authors are really building here is an argument for a more physically credible cell delivery format. The interest is not just that the cells can be pushed toward an NP-like phenotype. It is that they can be assembled into an injectable microtissue for nucleus pulposus regeneration that behaves differently under compression and injection than a spheroid alone.

That distinction is worth keeping. In practice, a lot of regenerative strategies look promising until the delivery step is considered seriously. The disc is not an easy target, and the route into the disc is not especially forgiving. The scaffolded spheroid approach appears to address that tension in a practical way by reinforcing the construct without abandoning the biological logic of spheroid culture.

There are still limits here. The work was performed in vitro, with one donor source, and it does not attempt to show long-term repair in a living disc. Those boundaries are fairly clear. Still, the study gives a useful view of how nucleus pulposus regeneration can be framed not only as a differentiation problem, but also as a mechanics and delivery problem.

Citation

Overview of the CellScale MicroTester

The MicroTester is used in studies like this when researchers need to measure the mechanical behaviour of small, soft samples under controlled loading. That may include spheroids, microtissues, hydrogels, small biomaterial constructs, or other delicate specimens that are difficult to test with conventional mechanical systems.

In this publication, the MicroTester was used for cyclic compression testing of individual microscaffolds, spheroids, and scaffolded spheroids. That gave the researchers a way to compare force retention, structural response over repeated cycles, and apparent modulus at the same scale as the constructs themselves. For a study centered on nucleus pulposus regeneration, that kind of measurement is useful for a fairly practical reason. The construct they are testing is tiny, soft, and meant to be injected into a part of the body that experiences load. It is not enough for it to look intact under the microscope. The question is whether it actually resists deformation differently once the scaffold is added, and whether those differences hold up when the construct is compressed repeatedly.

That is really where the MicroTester fits into papers like this more generally. Researchers use it when they want to see whether a design change, a material change, or even a change in culture condition shows up in the mechanical response of the sample itself. In other words, it helps move the discussion beyond appearance and marker expression and into what the construct physically does under load. In cases like this one, that can help clarify whether a structural change in the construct is mostly visual, or whether it meaningfully changes how the construct responds to load.

Learn more here: CellScale MicroTester product page.